2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Subthalamic neuromodulation restores motor learning in Parkinson’s disease

A.L. Marcelino, A. Horn, A. Kühn, W.J. Neumann (Berlin, Germany)
Subthalamic nucleus deep brain stimulation evoked neural activity predicts clinical response to DBS

S. Xu, N. Sinclair, K. Bulluss, T. Perera, W. Lee, H. McDermott, W. Thevathasan (East Melbourne, Australia)
Subthalamic Nucleus Local Field Potential Beta Activity in Chinese Advanced PD Patients

J. Wu, J. Li, C. Xu, S. Mei, Y. Zhang (Minneapolis, MN, USA)
Subthalamic nucleus stimulation normalises effort-based decision-making in Parkinson’s disease

C. Atkinson-Clement, E. Cavazzini, A. Zénon, T. Witjas, F. Fluchère, C. Baunez, JP. Azulay, A. Eusebio (Aix-en-Provence, France)
Subthalamic theta oscillations in Parkinson’s disease

C. Oehrn, I. Weber, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)
Suicide attempts, suicidal and death ideation in Parkinson’s disease

MM. Dumitru, A. Papari (Iasi, Romania)
Superior cerebellar peduncles atrophy of PSP on PADRE imaging; comparison with idiopathic PD

S. Kakeda, M. Miyata, T. Yoneda, S. Ide, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)
SURE-PD3 Trial Participant Features prior to Randomization

E. Macklin, A. Videnovic, C. Lungu, C. Kamp, C. Casaceli, D. Oakes, A. Ascherio, M. Schwarzschild; on behalf of the Parkinson Study Group SURE-PD3_Investigators (Boston, MA, USA)
Surface mechanised nano-formulation of naringenin as adenosine A2A receptor antagonist against in Neurological associated problem of Parkinson

V. Kumar (Allahabad, India)
Surface Modified Solid Lipid Nanoparticles for the targeted delivery to brain: Management of HIV-1 Associated Dementia

S. Bhargava, V. Bhargava (Kanpur, India)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z